Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis

被引:26
作者
Aitken, ML
Greene, KE
Tonelli, MR
Burns, JL
Emerson, JC
Goss, CH
Gibson, RL
机构
[1] Univ Washington, Dept Med, Div Pulm & Crit Care, Seattle, WA USA
[2] Childrens Hosp & Reg Med Ctr, Dept Pediat, Seattle, WA USA
[3] Univ Colorado, Denver, CO 80202 USA
关键词
cystic fibrosis; hypertonic saline; sputum;
D O I
10.1378/chest.123.3.792
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Sputum induction (SI) is a noninvasive tool for sampling inflamed airways. The purpose of this study was to determine the optimal duration of collection in patients with cystic fibrosis (CF). The hypothesis was that the duration of SI collection would quantitatively and qualitatively alter the content of the induced sputum. Methods: In 10 clinically stable patients with CF (mean+/-SD age, 28+/-7 years; mean FEV1, 2.6+/-0.7 L), SI was performed with 3% hypertonic saline solution at five time points over 20 min. Results: SI was well tolerated, with an average maximum fall in FEV1 of 7+/-7%. The sample volumes, urea concentrations, interleukin-8 concentrations, total cell counts, and nonsquamous cell counts remained constant (p>0.05). The percentage of neutrophils decreased from 89+/-5% to 86+/-4% (p=0.03), and the percentage of alveolar macrophages increased 5+/-2% to 8+/-4% (p<0.01). The mean quantitative microbiological counts of nonmucoid Pseudomonas aeruginosa and Staphylococcus aureus decreased over the 20-min time period each by half a log (p=0.05 and p<0.01, respectively). Surfactant protein-A concentration increased from 1.6+/-0.3 to 2.4+/-0.4 ng/mL (log(10); p<0.001). Conclusions: We conclude that aliquots of induced sputum are similar in clinically stable patients with CF during 4-min intervals, although there is more alveolar sampling after 20 min. When induced-sputum samples are fractionated for research monitoring of inflammatory or microbiologic indexes, power calculations accounting for these variations over time are required.
引用
收藏
页码:792 / 799
页数:8
相关论文
共 44 条
  • [21] Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
    Keatings, VM
    Collins, PD
    Scott, DM
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) : 530 - 534
  • [22] KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075
  • [23] Kips JC, 1998, EUR RESPIR J, V11, p9S
  • [24] LEUKOTRIENE-B4 MARKEDLY ELEVATED IN THE EPITHELIAL LINING FLUID OF PATIENTS WITH CYSTIC-FIBROSIS
    KONSTAN, MW
    WALENGA, RW
    HILLIARD, KA
    HILLIARD, JB
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04): : 896 - 901
  • [25] BRONCHOALVEOLAR LAVAGE FINDINGS IN CYSTIC-FIBROSIS PATIENTS WITH STABLE, CLINICALLY MILD LUNG-DISEASE SUGGEST ONGOING INFECTION AND INFLAMMATION
    KONSTAN, MW
    HILLIARD, KA
    NORVELL, TM
    BERGER, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (02) : 448 - 454
  • [26] MODULATION OF AIRWAY INFLAMMATION IN CYSTIC-FIBROSIS - INVIVO SUPPRESSION OF INTERLEUKIN-8 LEVELS ON THE RESPIRATORY EPITHELIAL SURFACE BY AEROSOLIZATION OF RECOMBINANT SECRETORY LEUKOPROTEASE INHIBITOR
    MCELVANEY, NG
    NAKAMURA, H
    BIRRER, P
    HEBERT, CA
    WONG, WL
    ALPHONSO, M
    BAKER, JB
    CATALANO, MA
    CRYSTAL, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) : 1296 - 1301
  • [27] AEROSOL ALPHA-1-ANTITRYPSIN TREATMENT FOR CYSTIC-FIBROSIS
    MCELVANEY, NG
    HUBBARD, RC
    BIRRER, P
    CHERNICK, MS
    CAPLAN, DB
    FRANK, MM
    CRYSTAL, RG
    [J]. LANCET, 1991, 337 (8738) : 392 - 394
  • [28] Regional variability of lung inflammation in cystic fibrosis
    Meyer, KC
    Sharma, A
    Rosenthal, NS
    Peterson, K
    Brennan, L
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (05) : 1536 - 1540
  • [29] Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
    Nixon, GM
    Armstrong, DS
    Carzino, R
    Carlin, JB
    Olinsky, A
    Robertson, CF
    Grimwood, K
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (05) : 699 - 704
  • [30] ORDONEZ C, 2000, PEDIATR PULM, V20, pA319